Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity

Svensson, Daniel LU ; Lagerstedt, Jens O. LU ; Nilsson, Bengt Olof LU orcid and Del Giudice, Rita LU (2017) In Biochemical and Biophysical Research Communications 493(1). p.71-76
Abstract

The human cathelicidin peptide LL-37 has antimicrobial and anti-biofilm functions, but LL-37 may also damage the host by triggering inflammation and exerting a cytotoxic effect, thereby reducing host cell viability. Human plasma mitigates LL-37-induced host cell cytotoxicity but the underlying mechanisms are not completely understood. Apolipoprotein A-I (ApoA-I) is a plasma protein endowed with atheroprotective effects. Here, we investigate the interaction between ApoA-I and LL-37 by biochemical techniques, and furthermore assess if ApoA-I protects against LL-37-evoked cytotoxicity in human umbilical vein endothelial cells (HUVEC). Our results demonstrated that ApoA-I effectively binds LL-37. The binding of ApoA-I to LL-37 resulted in a... (More)

The human cathelicidin peptide LL-37 has antimicrobial and anti-biofilm functions, but LL-37 may also damage the host by triggering inflammation and exerting a cytotoxic effect, thereby reducing host cell viability. Human plasma mitigates LL-37-induced host cell cytotoxicity but the underlying mechanisms are not completely understood. Apolipoprotein A-I (ApoA-I) is a plasma protein endowed with atheroprotective effects. Here, we investigate the interaction between ApoA-I and LL-37 by biochemical techniques, and furthermore assess if ApoA-I protects against LL-37-evoked cytotoxicity in human umbilical vein endothelial cells (HUVEC). Our results demonstrated that ApoA-I effectively binds LL-37. The binding of ApoA-I to LL-37 resulted in a structural rearrangement of the protein, but this interaction did not cause lower ApoA-I stability. Recombinant ApoA-I protected against LL-37-induced cytotoxicity in HUVEC and endogenous ApoA-I knockdown in HepG2 cells made the cells more sensitive to LL-37-evoked cytotoxicity. We conclude that ApoA-I physically interacts with LL-37 and antagonizes LL-37-induced down-regulation of endothelial cell viability suggesting that this mechanism counteracts endothelial cell dysfunction.

(Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Antimicrobial peptide (AMP), ApoA-I, Cathelicidin, Endothelium, Host defence peptide, Innate immunity
in
Biochemical and Biophysical Research Communications
volume
493
issue
1
pages
71 - 76
publisher
Elsevier
external identifiers
  • scopus:85029552786
  • pmid:28919413
  • wos:000413134200012
ISSN
0006-291X
DOI
10.1016/j.bbrc.2017.09.072
language
English
LU publication?
yes
id
ae3fac7a-daf5-40df-869d-96dd4a003e61
date added to LUP
2017-10-04 10:27:59
date last changed
2024-02-13 07:57:27
@article{ae3fac7a-daf5-40df-869d-96dd4a003e61,
  abstract     = {{<p>The human cathelicidin peptide LL-37 has antimicrobial and anti-biofilm functions, but LL-37 may also damage the host by triggering inflammation and exerting a cytotoxic effect, thereby reducing host cell viability. Human plasma mitigates LL-37-induced host cell cytotoxicity but the underlying mechanisms are not completely understood. Apolipoprotein A-I (ApoA-I) is a plasma protein endowed with atheroprotective effects. Here, we investigate the interaction between ApoA-I and LL-37 by biochemical techniques, and furthermore assess if ApoA-I protects against LL-37-evoked cytotoxicity in human umbilical vein endothelial cells (HUVEC). Our results demonstrated that ApoA-I effectively binds LL-37. The binding of ApoA-I to LL-37 resulted in a structural rearrangement of the protein, but this interaction did not cause lower ApoA-I stability. Recombinant ApoA-I protected against LL-37-induced cytotoxicity in HUVEC and endogenous ApoA-I knockdown in HepG2 cells made the cells more sensitive to LL-37-evoked cytotoxicity. We conclude that ApoA-I physically interacts with LL-37 and antagonizes LL-37-induced down-regulation of endothelial cell viability suggesting that this mechanism counteracts endothelial cell dysfunction.</p>}},
  author       = {{Svensson, Daniel and Lagerstedt, Jens O. and Nilsson, Bengt Olof and Del Giudice, Rita}},
  issn         = {{0006-291X}},
  keywords     = {{Antimicrobial peptide (AMP); ApoA-I; Cathelicidin; Endothelium; Host defence peptide; Innate immunity}},
  language     = {{eng}},
  month        = {{09}},
  number       = {{1}},
  pages        = {{71--76}},
  publisher    = {{Elsevier}},
  series       = {{Biochemical and Biophysical Research Communications}},
  title        = {{Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity}},
  url          = {{http://dx.doi.org/10.1016/j.bbrc.2017.09.072}},
  doi          = {{10.1016/j.bbrc.2017.09.072}},
  volume       = {{493}},
  year         = {{2017}},
}